Stockchase Opinions

Werner Muehelemann AEterna Zentaris Inc. AEZS-T BUY ON WEAKNESS Sep 07, 2004

Would like to get in at the $6 level. Cash flow positive.
$7.420

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
His stock filter picked stocks on a momentum basis and where money was flowing into them. The low it hit recently is a meaningful low. Likes the sector and feels it has been oversold. Do not let it violate the March low.
SELL
Rather bad couple of days. Was down substantially, outside of a range. Consolidated. It broke down and is more likely to go down. $1.50 on the downside.